PetMed Express Announces Leadership Transition Amid CEO and CFO Resignations.

PetMed Express, a leader in the direct-to-consumer pet healthcare industry, has announced the resignation of its CEO and CFO. Leslie Campbell, the Chair of the Board, has been appointed Interim CEO, while Douglas Krulik will serve as Interim Principal Financial Officer. The company is searching for permanent replacements for the key leadership roles.

PetMed Express, Inc. (NASDAQ: PETS), a leading player in the direct-to-consumer pet healthcare sector, has announced significant leadership changes. The company's Chief Executive Officer (CEO), Sandra Campos, and Chief Financial Officer (CFO), Robyn D’Elia, have resigned from their positions. Leslie C.G. Campbell, Chair of the Board, has been appointed as Interim CEO, while Douglas Krulik, the Chief Accounting Officer, has been appointed as Interim Principal Financial Officer [1].

The resignations follow a series of recent changes within the company, including the appointment of Peter Batushansky to the Board of Directors and the announcement of preliminary fourth-quarter and fiscal year 2025 results [2]. The company has initiated a search for permanent replacements for the key leadership roles.

In connection with their resignations, Ms. Campos and Ms. D’Elia have entered into separation agreements with the company, under which they will receive severance payments and provide consulting services for a period of three months [3]. Ms. Campos also resigned from the Board of Directors, reducing the board size to five members.

The leadership changes come amid ongoing investigations by the company's Audit Committee and other risks described in the company's filings with the Securities and Exchange Commission. The company has not provided specific details on the reasons behind the resignations or the ongoing investigations.

PetMed Express has a strong presence in the pet healthcare market, offering a range of solutions including top-brand and generic pharmaceuticals, compounded medications, and better-for-your-pet OTC supplements and nutrition. The company's focus on value, convenience, and care has positioned it as a trusted national online pharmacy [3].

The stock price of PetMed Express has seen fluctuations in response to the leadership changes, with shares down 13% post-market on Tuesday [2]. The company's forward-looking statements indicate that actual results could differ materially from those anticipated due to various risks and uncertainties.

References:
[1] https://www.marketscreener.com/news/petmed-express-ceo-and-cfo-resign-ce7c51dade8ff527
[2] https://seekingalpha.com/news/4484215-petmed-express-ceo-and-cfo-resign-board-chair-named-interim-ceo
[3] https://www.morningstar.com/news/globe-newswire/9511279/petmed-express-inc-announces-management-changes